Search
Search Constraints
You searched for: Author/Creator Martins, IlidioLimit your search
- Martins, Ilidio [remove] 1
- 616.99406 1
- A-TARE ablative transarterial radioembolization -- AE adverse event -- AFP alphafetoprotein -- BCLC Barcelona clinic liver cancer (staging) -- BCLC-A BCLC stage A, early-stage disease -- BCLC-B BCLC stage B, intermediate-stage disease -- BCLC-C BCLC stage C, advanced-stage disease -- CSPH clinically-significant portal hypertension -- cTACE conventional transarterial chemoembolization -- DEB-TACE drug-eluting bead transarterial chemoembolization -- EHS extrahepatic spread -- EBRT external beam radiation therapy -- HAE hepatic arterial embolization -- HCC hepatocellular carcinoma -- HKLC Hong Kong liver cancer (staging) -- HR hazard ratio -- HVPG hepatic venous pressure gradient -- IAT intra-arterial therapy (aka. HAT, hepatic artery-based therapy or trans-arterial therapy) -- ICI immune checkpoint inhibitor -- IRE irreversible electroporation -- LRT locoregional therapy -- LT liver transplantation -- MWA microwave ablation -- ORR overall response rate -- OS overall survival -- PFS progression-free survival -- PS performance status -- RCT randomized controlled trial -- RFA radiofrequency ablation -- SBRT stereotactic body radiation therapy -- TACE transarterial chemoembolization -- TKI tyrosine kinase inhibitor -- TTP time to progression -- TTV total tumor volume -- Y90-TARE transarterial radioembolization using the Yttrium-90 (Y90) isotope 1
- Cancer -- Periodicals 1
- Cancer -- Périodiques 1
- Cancer -- Traitement -- Périodiques 1
- Cancer -- Treatment 1
- Cancer -- Treatment -- Periodicals 1
- Electronic journals 1
- Hepatocellular carcinoma -- Intermediate-stage disease -- Locoregional therapy -- Systemic therapy -- Radiotherapy -- Surgery 1
- Neoplasms -- therapy -- Periodicals 1